Downloads

Johnson & Johnson:
Medical Device & Diagnostics

A time of change and challenge

Johnson & Johnson is a holding company that comprises more than 250 healthcare companies located in 60 countries throughout the world. In terms of revenue, the company claims to be the world’s largest medical device company, the sixth-largest consumer healthcare company, the eighth-largest pharmaceucticals business and the sixth-largest biologics company. The group’s structure is based around three business segments – Medical Devices & Diagnostics, Pharmaceuticals and Consumer.

• The Consumer segment includes a broad range of products used in the Johnson’s-branded baby care, skin care (the Aveeno, Clean & Clear, Johnson’s Adult, Neutrogena, RoC, Lubrider, Dabao and Vendôme lines), oral care (including the Listerine and Reach products), wound care (Band-Aid and Purell brands) and women’s healthcare (Carefree, Stayfree and Vania-branded products) fields, as well as nutritional and over-the-counter pharmaceutical products, such as Splenda sweetener, Tylenol acetaminophen products, Sudafed cold, flu and allergy products, Zyrtec allergy products, Motrin IB ibuprofen products and Pepcid AC Acid Controller from Johnson & Johnson Merck Consumer Pharmaceuticals Co.
• The Pharmaceuticals segment includes products in the following therapeutic areas: anti infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastro-intestinal, haematology, immunology, neurology, oncology, pain management, urology and virology. Its most prominent brands include Remicade, Stelara, Simponi, Zytiga, Intelence, Edurant, Incivo, Nucynta, Sustenna, Procrit (or Eprex outside of the US), Xarelto, Levaquin, Risperdal Consta, Concerta, Aciphex/Pariet, Duragesic (or Durogesic outside of the US), Velcade, Prezista and Invega.

• The Medical Devices & Diagnostics segment is divided into various franchises that produce a broad range of products including: Cardiovascular Care, consisting of Cordis and Biosense Webster electrophysiology and circulatory disease management products; DePuy’s orthopaedic joint reconstruction, spinal care, neurological and sports medicine products; Ethicon’s sutures, tissue repair and reinforcement products, women’s health, aesthetics and conditions of the ear, nose and throat products; Ethicon Endo-Surgery’s minimally-invasive surgical products and advanced sterilisation products; Diabetes Care, including LifeScan and Animas blood glucose monitoring and insulin delivery products; Ortho-Clinical Diagnostics’ professional diagnostic products; and Vision Care, comprising Vistakon’s disposable contact lenses.

This report mainly focuses on the activities and performances of Johnson & Johnson’s Medical Devices businesses, which hold the No 1 or 2 market positions in the majority of their markets.

In addition to advancing its product pipelines through internal development, alliances or significant equity investments, Johnson & Johnson has acquired several companies to enhance the growth and create long-term value for its Medical Devices & Diagnostics business. Typical examples include the acquisitions of: Micrus Endovascular, a developer and manufacturer of minimally-invasive devices for haemorrhagic and ischaemic stroke; Finsbury Orthopaedics, a manufacturer and global distributor of orthopaedic implants; Acclarent, a medical technology company dedicated to designing, developing and commercialising devices that address conditions affecting the ear, nose and throat; Gloster Europe, a developer of area-decontamination technologies to help prevent healthcare-acquired infections; Mentor, a supplier of medical products for the aesthetic market; and SterilMed, a reprocessor of surgical instruments.

The Johnson & Johnson Medical Device & Diagnostics Company Report provides a full review of the company's medical device activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures and litigation. Sections are also included on products, corporate strategy and R&D.

Whatever your interest or involvement, evaluating the performance, success, failures and developments of medical companies is critical. Espicom’s Medical Device Company Reports have been regularly published for over 20 years, and these critically acclaimed and respected management reports provide a complete review of leading players in the field.

Key Benefits

• Evaluate competitive threats
• Maximise product and market opportunities
• Identify collaborators and strategic partners
• Understand the operating market environment
• Benchmark your performance against competitors

Coverage Overview

• Key contact information
• Introduction to Johnson & Johnson Medical Device & Diagnostics and its current activities
• Summary of its financial performance
• Key recent events in an “at a glance” format

Strategic Focus

• The company’s aims and its areas of focus

Financial Review

• Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
• Table providing in-depth five-year financial analysis
• Employee data, including breakdown by company division and geographic location

Product Overview

• Core product areas, key brands, product approvals and launches
• Identifies the company’s major competitors

Research and Development

• How much has been invested in R&D?
• Where is the research based?
• What alliances and agreements does Johnson & Johnson Medical Device & Diagnostics have and with whom?

Manufacturing and Distribution

• Identifying the company’s manufacturing locations
• Sales and marketing facilities

Agreements

• With whom has Johnson & Johnson Medical Device & Diagnostics reached agreements and what do they involve?
• Key contracts awarded

Mergers and Acquisitions

Minority Divestments

Litigation

Key Corporate Events

The report was produced as part of Medical Device Companies Analysis (MDCA). For more information on MDCA, click here.